APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Therapy Products

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gene Therapy Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025180 pages

Choose your research edition.

Industry ResearchGene Therapy Products Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Therapy Products Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Gene Therapy Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Therapy Products Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Therapy Products Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Gene Therapy Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gene Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gene Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gene Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gene Therapy Products include Advantagene, Avalanche Bio, Bluebird Bio, Celladon, Dimension Therapeutics, Sangamo, Spark Therapeutics and Vical Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gene Therapy Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gene Therapy Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gene Therapy Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gene Therapy Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Gene Therapy Products Segment by Company

Advantagene

Avalanche Bio

Bluebird Bio

Celladon

Dimension Therapeutics

Sangamo

Spark Therapeutics

Vical Inc.

Gene Therapy Products Segment by Type

Ex vivo

In Vivo

Gene Therapy Products Segment by Application

Cardiovascular disease

Monogenic

Infectious disease

Cancer

Other

Gene Therapy Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapy Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Therapy Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapy Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gene Therapy Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gene Therapy Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gene Therapy Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gene Therapy Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gene Therapy Products Industry Trends Table 2. Gene Therapy Products Industry Drivers Table 3. Gene Therapy Products Industry Opportunities and Challenges Table 4. Gene Therapy Products Industry Restraints Table 5. Global Gene Therapy Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gene Therapy Products Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gene Therapy Products Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Gene Therapy Products Sales Market Share by Manufacturers Table 9. Global Gene Therapy Products Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Gene Therapy Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gene Therapy Products Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gene Therapy Products Manufacturers, Product Type & Application Table 13. Global Gene Therapy Products Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gene Therapy Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Ex vivo Table 17. Major Manufacturers of In Vivo Table 18. Global Gene Therapy Products Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 20. Global Gene Therapy Products Sales by Type (2027-2032) & (K Units) Table 21. Global Gene Therapy Products Sales Market Share by Type (2021-2026) Table 22. Global Gene Therapy Products Sales Market Share by Type (2027-2032) Table 23. Global Gene Therapy Products Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Gene Therapy Products Revenue by Type (2021-2026) & (K Units) Table 25. Global Gene Therapy Products Revenue by Type (2027-2032) & (K Units) Table 26. Global Gene Therapy Products Revenue Market Share by Type (2021-2026) Table 27. Global Gene Therapy Products Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cardiovascular disease Table 29. Major Manufacturers of Monogenic Table 30. Major Manufacturers of Infectious disease Table 31. Major Manufacturers of Cancer Table 32. Major Manufacturers of Other Table 33. Global Gene Therapy Products Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 35. Global Gene Therapy Products Sales by Application (2027-2032) & (K Units) Table 36. Global Gene Therapy Products Sales Market Share by Application (2021-2026) Table 37. Global Gene Therapy Products Sales Market Share by Application (2027-2032) Table 38. Global Gene Therapy Products Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Gene Therapy Products Revenue by Application (2021-2026) & (K Units) Table 40. Global Gene Therapy Products Revenue by Application (2027-2032) & (K Units) Table 41. Global Gene Therapy Products Revenue Market Share by Application (2021-2026) Table 42. Global Gene Therapy Products Revenue Market Share by Application (2027-2032) Table 43. Global Gene Therapy Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Gene Therapy Products Sales by Region (2021-2026) & (K Units) Table 45. Global Gene Therapy Products Sales Market Share by Region (2021-2026) Table 46. Global Gene Therapy Products Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Gene Therapy Products Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Gene Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 50. North America Gene Therapy Products Sales by Country (2027-2032) & (K Units) Table 51. Europe Gene Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 53. Europe Gene Therapy Products Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Gene Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Gene Therapy Products Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Gene Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Gene Therapy Products Sales by Country (2027-2032) & (K Units) Table 60. Global Gene Therapy Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Gene Therapy Products Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Gene Therapy Products Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Gene Therapy Products Revenue Market Share by Region (2021-2026) Table 64. Global Gene Therapy Products Revenue Market Share by Region (2027-2032) Table 65. Advantagene Company Information Table 66. Advantagene Business Overview Table 67. Advantagene Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Advantagene Gene Therapy Products Product Portfolio Table 69. Advantagene Recent Development Table 70. Avalanche Bio Company Information Table 71. Avalanche Bio Business Overview Table 72. Avalanche Bio Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Avalanche Bio Gene Therapy Products Product Portfolio Table 74. Avalanche Bio Recent Development Table 75. Bluebird Bio Company Information Table 76. Bluebird Bio Business Overview Table 77. Bluebird Bio Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Bluebird Bio Gene Therapy Products Product Portfolio Table 79. Bluebird Bio Recent Development Table 80. Celladon Company Information Table 81. Celladon Business Overview Table 82. Celladon Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Celladon Gene Therapy Products Product Portfolio Table 84. Celladon Recent Development Table 85. Dimension Therapeutics Company Information Table 86. Dimension Therapeutics Business Overview Table 87. Dimension Therapeutics Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Dimension Therapeutics Gene Therapy Products Product Portfolio Table 89. Dimension Therapeutics Recent Development Table 90. Sangamo Company Information Table 91. Sangamo Business Overview Table 92. Sangamo Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Sangamo Gene Therapy Products Product Portfolio Table 94. Sangamo Recent Development Table 95. Spark Therapeutics Company Information Table 96. Spark Therapeutics Business Overview Table 97. Spark Therapeutics Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Spark Therapeutics Gene Therapy Products Product Portfolio Table 99. Spark Therapeutics Recent Development Table 100. Vical Inc. Company Information Table 101. Vical Inc. Business Overview Table 102. Vical Inc. Gene Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Vical Inc. Gene Therapy Products Product Portfolio Table 104. Vical Inc. Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Gene Therapy Products Distributors List Table 108. Gene Therapy Products Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Gene Therapy Products Product Image Figure 2. Global Gene Therapy Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Therapy Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Gene Therapy Products Sales (2021-2032) & (K Units) Figure 5. Global Gene Therapy Products Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Gene Therapy Products Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Ex vivo Image Figure 9. In Vivo Image Figure 10. Global Gene Therapy Products Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Gene Therapy Products Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Gene Therapy Products Sales Market Share by Type (2021-2032) Figure 13. Global Gene Therapy Products Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Gene Therapy Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Gene Therapy Products Revenue Market Share by Type (2021-2032) Figure 16. Cardiovascular disease Image Figure 17. Monogenic Image Figure 18. Infectious disease Image Figure 19. Cancer Image Figure 20. Other Image Figure 21. Global Gene Therapy Products Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Gene Therapy Products Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Gene Therapy Products Sales Market Share by Application (2021-2032) Figure 24. Global Gene Therapy Products Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Gene Therapy Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Gene Therapy Products Revenue Market Share by Application (2021-2032) Figure 27. North America Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Gene Therapy Products Sales Market Share by Country (2021-2032) Figure 29. U.S. Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Gene Therapy Products Sales Market Share by Country (2021-2032) Figure 34. Germany Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Gene Therapy Products Sales Market Share by Country (2021-2032) Figure 41. China Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Gene Therapy Products Sales Market Share by Country (2021-2032) Figure 49. Brazil Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Gene Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Gene Therapy Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Gene Therapy Products Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Gene Therapy Products Revenue (2021-2032) & (US$ Million) Figure 60. North America Gene Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Gene Therapy Products Revenue (2021-2032) & (US$ Million) Figure 62. Europe Gene Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Gene Therapy Products Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Gene Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Gene Therapy Products Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Gene Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Gene Therapy Products Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Gene Therapy Products Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Ex vivo
  • In Vivo
Applications
  • Cardiovascular disease
  • Monogenic
  • Infectious disease
  • Cancer
  • Other
Companies covered
  • Advantagene
  • Avalanche Bio
  • Bluebird Bio
  • Celladon
  • Dimension Therapeutics
  • Sangamo
  • Spark Therapeutics
  • Vical Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gene Therapy Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gene Therapy Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gene Therapy Products Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gene Therapy Products Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gene Therapy Products Market Dynamics
  1. 2.1 Gene Therapy Products Industry Trends
  2. 2.2 Gene Therapy Products Industry Drivers
  3. 2.3 Gene Therapy Products Industry Opportunities and Challenges
  4. 2.4 Gene Therapy Products Industry Restraints
3 Gene Therapy Products Market by Manufacturers
  1. 3.1 Global Gene Therapy Products Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gene Therapy Products Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gene Therapy Products Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gene Therapy Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gene Therapy Products Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gene Therapy Products Manufacturers, Product Type & Application
  7. 3.7 Global Gene Therapy Products Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gene Therapy Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gene Therapy Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gene Therapy Products Tier 1, Tier 2, and Tier 3
4 Gene Therapy Products Market by Type
  1. 4.1 Gene Therapy Products Type Introduction
  2. 4.1.1 Ex vivo
  3. 4.1.2 In Vivo
  4. 4.2 Global Gene Therapy Products Sales by Type
  5. 4.2.1 Global Gene Therapy Products Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gene Therapy Products Sales by Type (2021-2032)
  7. 4.2.3 Global Gene Therapy Products Sales Market Share by Type (2021-2032)
  8. 4.3 Global Gene Therapy Products Revenue by Type
  9. 4.3.1 Global Gene Therapy Products Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gene Therapy Products Revenue by Type (2021-2032)
  11. 4.3.3 Global Gene Therapy Products Revenue Market Share by Type (2021-2032)
5 Gene Therapy Products Market by Application
  1. 5.1 Gene Therapy Products Application Introduction
  2. 5.1.1 Cardiovascular disease
  3. 5.1.2 Monogenic
  4. 5.1.3 Infectious disease
  5. 5.1.4 Cancer
  6. 5.1.5 Other
  7. 5.2 Global Gene Therapy Products Sales by Application
  8. 5.2.1 Global Gene Therapy Products Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Gene Therapy Products Sales by Application (2021-2032)
  10. 5.2.3 Global Gene Therapy Products Sales Market Share by Application (2021-2032)
  11. 5.3 Global Gene Therapy Products Revenue by Application
  12. 5.3.1 Global Gene Therapy Products Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Gene Therapy Products Revenue by Application (2021-2032)
  14. 5.3.3 Global Gene Therapy Products Revenue Market Share by Application (2021-2032)
6 Global Gene Therapy Products Sales by Region
  1. 6.1 Global Gene Therapy Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gene Therapy Products Sales by Region (2021-2032)
  3. 6.2.1 Global Gene Therapy Products Sales by Region (2021-2026)
  4. 6.2.2 Global Gene Therapy Products Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gene Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gene Therapy Products Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gene Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gene Therapy Products Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gene Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gene Therapy Products Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gene Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gene Therapy Products Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gene Therapy Products Revenue by Region
  1. 7.1 Global Gene Therapy Products Revenue by Region
  2. 7.1.1 Global Gene Therapy Products Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gene Therapy Products Revenue by Region (2021-2026)
  4. 7.1.3 Global Gene Therapy Products Revenue by Region (2027-2032)
  5. 7.1.4 Global Gene Therapy Products Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gene Therapy Products Revenue (2021-2032)
  8. 7.2.2 North America Gene Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gene Therapy Products Revenue (2021-2032)
  11. 7.3.2 Europe Gene Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gene Therapy Products Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gene Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gene Therapy Products Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gene Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Advantagene
  2. 8.1.1 Advantagene Company Information
  3. 8.1.2 Advantagene Business Overview
  4. 8.1.3 Advantagene Gene Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Advantagene Gene Therapy Products Product Portfolio
  6. 8.1.5 Advantagene Recent Developments
  7. 8.2 Avalanche Bio
  8. 8.2.1 Avalanche Bio Company Information
  9. 8.2.2 Avalanche Bio Business Overview
  10. 8.2.3 Avalanche Bio Gene Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Avalanche Bio Gene Therapy Products Product Portfolio
  12. 8.2.5 Avalanche Bio Recent Developments
  13. 8.3 Bluebird Bio
  14. 8.3.1 Bluebird Bio Company Information
  15. 8.3.2 Bluebird Bio Business Overview
  16. 8.3.3 Bluebird Bio Gene Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bluebird Bio Gene Therapy Products Product Portfolio
  18. 8.3.5 Bluebird Bio Recent Developments
  19. 8.4 Celladon
  20. 8.4.1 Celladon Company Information
  21. 8.4.2 Celladon Business Overview
  22. 8.4.3 Celladon Gene Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Celladon Gene Therapy Products Product Portfolio
  24. 8.4.5 Celladon Recent Developments
  25. 8.5 Dimension Therapeutics
  26. 8.5.1 Dimension Therapeutics Company Information
  27. 8.5.2 Dimension Therapeutics Business Overview
  28. 8.5.3 Dimension Therapeutics Gene Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dimension Therapeutics Gene Therapy Products Product Portfolio
  30. 8.5.5 Dimension Therapeutics Recent Developments
  31. 8.6 Sangamo
  32. 8.6.1 Sangamo Company Information
  33. 8.6.2 Sangamo Business Overview
  34. 8.6.3 Sangamo Gene Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sangamo Gene Therapy Products Product Portfolio
  36. 8.6.5 Sangamo Recent Developments
  37. 8.7 Spark Therapeutics
  38. 8.7.1 Spark Therapeutics Company Information
  39. 8.7.2 Spark Therapeutics Business Overview
  40. 8.7.3 Spark Therapeutics Gene Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Spark Therapeutics Gene Therapy Products Product Portfolio
  42. 8.7.5 Spark Therapeutics Recent Developments
  43. 8.8 Vical Inc.
  44. 8.8.1 Vical Inc. Company Information
  45. 8.8.2 Vical Inc. Business Overview
  46. 8.8.3 Vical Inc. Gene Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vical Inc. Gene Therapy Products Product Portfolio
  48. 8.8.5 Vical Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gene Therapy Products Value Chain Analysis
  2. 9.1.1 Gene Therapy Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gene Therapy Products Production Mode & Process
  6. 9.2 Gene Therapy Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gene Therapy Products Distributors
  9. 9.2.3 Gene Therapy Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst